CA2043366A1 - Dry eye treatment process and solution - Google Patents

Dry eye treatment process and solution

Info

Publication number
CA2043366A1
CA2043366A1 CA2043366A CA2043366A CA2043366A1 CA 2043366 A1 CA2043366 A1 CA 2043366A1 CA 2043366 A CA2043366 A CA 2043366A CA 2043366 A CA2043366 A CA 2043366A CA 2043366 A1 CA2043366 A1 CA 2043366A1
Authority
CA
Canada
Prior art keywords
solution
treatment process
dry eye
eye treatment
eye
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA2043366A
Other languages
French (fr)
Other versions
CA2043366C (en
Inventor
Thomas Glonek
Jack V. Greiner
Donald R. Korb
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ocular Research of Boston Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2043366A1 publication Critical patent/CA2043366A1/en
Application granted granted Critical
Publication of CA2043366C publication Critical patent/CA2043366C/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/04—Artificial tears; Irrigation solutions

Abstract

A method and composition for reducing evaporation of an aqueous layer from the surface of the eye. The method comprises applying an admixture of a charged phospholipid and a non-polar oil over the eye, preferably in the form of a meta-stable oil in water emulsion in a dosage not exceeding 100 microliters.
CA002043366A 1990-05-29 1991-05-28 Dry eye treatment process and solution Expired - Lifetime CA2043366C (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US52965790A 1990-05-29 1990-05-29
US07/529,657 1990-05-29
US63821591A 1991-01-07 1991-01-07
US07/638,215 1991-01-07

Publications (2)

Publication Number Publication Date
CA2043366A1 true CA2043366A1 (en) 1991-11-30
CA2043366C CA2043366C (en) 1999-01-05

Family

ID=27063077

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002043366A Expired - Lifetime CA2043366C (en) 1990-05-29 1991-05-28 Dry eye treatment process and solution

Country Status (12)

Country Link
US (1) US5294607A (en)
EP (1) EP0459148B1 (en)
JP (1) JP3281392B2 (en)
AT (1) ATE132366T1 (en)
AU (1) AU648304B2 (en)
CA (1) CA2043366C (en)
DE (1) DE69115990T2 (en)
ES (1) ES2084722T3 (en)
GR (1) GR3019478T3 (en)
IL (1) IL98237A (en)
RU (1) RU2092138C1 (en)
TW (1) TW200396B (en)

Families Citing this family (120)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5364632A (en) * 1989-04-05 1994-11-15 Yissum Research Development Company Of The Hebrew University Of Jerusalem Medicinal emulsions
ZA927277B (en) * 1991-10-02 1993-05-19 Boston Ocular Res Dry eye treatment process and solution.
EP0733918B1 (en) * 1995-03-24 2003-07-30 Ocular Research of Boston, Inc. Hydrogel lens pre-coated with lipid layer
DE19511322C2 (en) 1995-03-28 1999-09-02 Mann Gerhard Chem Pharm Fab Sterile eye gels containing medium chain triglycerides and process for their preparation
US5616342A (en) * 1995-04-11 1997-04-01 Pdt, Inc. Emulsioin suitable for administering a poorly water-soluble photosensitizing compound and use thereof
DE19527132A1 (en) * 1995-07-25 1997-01-30 Laevosan Gmbh & Co Kg Ophthalmic ozone protection composition
US5696166A (en) * 1995-10-31 1997-12-09 Yanni; John M. Compositions containing hydroxyeicosatetraenoic acid derivatives and methods of use in treating dry eye disorders
JPH10218760A (en) * 1997-02-04 1998-08-18 Nobel Igaku Kenkyusho:Kk Eye drop with small amount of oil added for treating dry eye
ZA989513B (en) 1997-10-21 1999-04-21 Alcon Lab Inc Compositions containing histamine H2 agonists and methods of use in treating dry eye
RU2125427C1 (en) * 1998-05-27 1999-01-27 Миронова Эмилия Михайловна Okovidit c eye disease drug
EP0982025A1 (en) * 1998-08-28 2000-03-01 Wilhelm Prof. Dr. Stoffel Synthetic tear fluid
WO2000038690A2 (en) 1998-12-24 2000-07-06 Alcon Laboratories, Inc. Prostaglandin e agonists for treatment of dry eye
AU2183900A (en) 1998-12-24 2000-07-31 Alcon Laboratories, Inc. Ep4 receptor agonists for treatment of dry eye
WO2000051619A1 (en) 1999-03-01 2000-09-08 Vista Scientific Llc Mucin containing ophthalmic preparations
AUPQ228199A0 (en) * 1999-08-18 1999-09-09 Sly, Anthony William Ophthalmic fluid
DK1228028T3 (en) 1999-11-09 2005-11-14 Alcon Inc Hydroxyicosatetraenoate salts, preparations and methods for use in the treatment of eye disorders
US6552084B2 (en) 1999-11-09 2003-04-22 Alcon Universal Ltd. Hydroxyeicosatetraenoic acid analogs and methods of their use in treating dry eye disorders
CA2386333A1 (en) 1999-11-09 2001-05-17 Alcon, Inc. 3-heteroatom substituted and two carbon homologs 15-hete and methods of use
WO2001034129A2 (en) 1999-11-09 2001-05-17 Alcon Universal Ltd. Heteroatom-interrupted analogs of 15-hydroxyeicosatetraenoic acid and methods of use
CN1387502A (en) 1999-11-09 2002-12-25 爱尔康公司 15-hydroxyeicosatetraenoic acid-related compounds and methods of use
ATE296792T1 (en) 1999-11-09 2005-06-15 Alcon Inc BENZENOID DERIVATIVES OF 15-HYDROXYEICOSATETRAENIC ACID AND METHOD OF USE FOR TREATING DRY EYE
US6255343B1 (en) 1999-11-09 2001-07-03 Alcon Universal Ltd. 2,2-difluoro 15-hydroxyeicosatetraenoic acid analogs and methods of use
US6458854B2 (en) 1999-11-09 2002-10-01 Alcon Universal Ltd. Phospholipids of hydroxyeicosatetraenoic acid-like derivatives and methods of use
DK1237549T3 (en) * 1999-11-09 2004-06-07 Alcon Inc Lipoxin A4 and its analogues for the treatment of dry eyes
TR200201251T2 (en) 1999-11-09 2002-11-21 Alcon, Inc. Omega chain modified 15-hydroxyiecosetetraenoic acid derivatives and their use methods for improving eye dryness
CN1387505A (en) 1999-11-09 2002-12-25 爱尔康公司 Compositions contg. hydroxyeicosatetraenoic acid derivs, and methods of use in treating dry eye disorders
AU1226001A (en) 1999-11-09 2001-06-06 Alcon Universal Limited Phospholipids of hydroxyeicosatetraenoic acid-like derivatives
AU8031400A (en) 1999-11-09 2001-06-06 Alcon Universal Limited 15-hydroxyeicosatetraenoic acid analogs with enhanced metabolic stability and methods of their use in treating dry eye disorders
US6803385B2 (en) 1999-11-09 2004-10-12 Alcon, Inc. Hydroxyeicosatetraenoic acid analogs and methods of their use in treating dry eye disorders
WO2001046134A1 (en) 1999-12-22 2001-06-28 Alcon Universal Ltd. 6-KETO PROSTAGLANDIN F1α AND ANALOGS FOR TREATING DRY EYE
US6348508B1 (en) 2000-04-04 2002-02-19 Bausch & Lomb Incorporated Method for treating dry eye
US7524511B1 (en) * 2000-07-12 2009-04-28 Rogue Valley Natural Springs, Inc. Method and kit for moisturizing the surface of the eye
KR20030026973A (en) * 2000-07-12 2003-04-03 로그 밸리 내츄럴 스프링즈 인코포레이티드 Method and kit for moisturizing the surface of the eye
BR0209965A (en) 2001-05-21 2004-04-06 Alcon Inc Use of nf-kappab inhibitors to treat dry eye disorders
DE60218153T2 (en) 2001-05-21 2007-06-28 Alcon Inc. USE OF PROTEASOME INHIBITORS FOR THE TREATMENT OF DRY EYES
US6872382B1 (en) 2001-05-21 2005-03-29 Alcon, Inc. Use of selective PDE IV inhibitors to treat dry eye disorders
PL367097A1 (en) * 2001-05-21 2005-02-21 Alcon, Inc. Method of treating dry eye disorders
US7112588B2 (en) * 2001-05-21 2006-09-26 Alcon, Inc. Use of proteasome inhibitors to treat dry eye disorders
US6645994B1 (en) 2001-06-01 2003-11-11 Alcon, Inc. Method of treating dry eye disorders
FR2827190A1 (en) * 2001-06-22 2003-01-17 Rhodia Chimie Sa USE OF AN OIL COMPRISING A POLAR GROUP AS AID FOR THE DEPOSITION OF NON-IONIZABLE POLAR OIL
US6750250B1 (en) * 2001-07-12 2004-06-15 Alcon, Inc. 11,12-oxidoarachidonic acid derivatives and methods of their use in treating dry eye disorders
DE10141018A1 (en) * 2001-08-22 2003-03-13 Eth Zuerich Eidgenoessische Te Use of negatively charged phospholipids and compositions comprising phospholipids for the treatment of the eye
US20040220089A1 (en) * 2001-10-03 2004-11-04 Ellis Edward J. Ophthalmic preparation containing glycoprotein
US20040214754A1 (en) * 2001-10-03 2004-10-28 Ellis Edward J. Ophthalmic preparation containing glycomacropeptide
WO2003030894A1 (en) * 2001-10-11 2003-04-17 Alcon, Inc. Methods for treating dry eye
CA2462272A1 (en) * 2001-10-11 2003-04-17 Alcon, Inc. Methods for treating dry eye by a combination of an antiinflammatory steroid and a muc-1 secretagogue
US6656460B2 (en) * 2001-11-01 2003-12-02 Yissum Research Development Method and composition for dry eye treatment
AU782913B2 (en) * 2001-11-02 2005-09-08 Santen Sas Method and composition for dry eye treatment
KR20060013632A (en) * 2002-05-17 2006-02-13 오쎄라 파마슈티걸즈, 인크. Amelioration of the development of cataracts and other opthalmic diseases
CN1684738A (en) * 2002-09-20 2005-10-19 爱尔康公司 Use of cytokine synthesis inhibitors for the treatment of dry eye disorders
WO2004060274A2 (en) * 2002-12-20 2004-07-22 Alcon, Inc. Treatment of dry eye by restoring 15-lipoxygenase activity to ocular surface cells
WO2004093878A1 (en) 2003-04-16 2004-11-04 Alcon, Inc. Use of fused pyridazine derivatives for treating dry eye disorders
US7825134B2 (en) * 2003-05-19 2010-11-02 Othera Holding, Inc. Amelioration of cataracts, macular degeneration and other ophthalmic diseases
EP1666027A4 (en) * 2003-09-10 2008-03-19 Senju Pharma Co Ophthalmic composition for contact lens
MXPA03011987A (en) 2003-12-19 2005-06-23 Osio Sancho Alberto Method for treating presbyopia by inducing changes in the corneal power and physiology.
US20070082017A1 (en) * 2004-01-10 2007-04-12 Tseng Scheffer C Lipid compositions and methods of use
US20050182039A1 (en) * 2004-02-13 2005-08-18 Bausch & Lomb Incorporated Use of Loteprednol etabonate for the treatment of dry eye
MXPA06010849A (en) 2004-03-25 2007-03-08 Bausch & Lomb Use of loteprednol etabonate for the treatment of dry eye.
US7923471B2 (en) * 2004-05-14 2011-04-12 Alcon, Inc. Method of treating dry eye disorders and uveitis
DK1744736T3 (en) * 2004-05-14 2010-02-15 Alcon Inc Procedure for treating problems with dry eyes and uveitis
MX2007000208A (en) * 2004-07-01 2007-08-07 Schepens Eye Res Inst Compositions and methods for treating eye disorders and conditions.
JP5272307B2 (en) * 2004-07-16 2013-08-28 大正製薬株式会社 Aqueous eye drops
US7223737B1 (en) 2004-08-13 2007-05-29 Alcon, Inc. Method of treating dry eye disorders using glycosides
CN101005834A (en) * 2004-08-27 2007-07-25 千寿制药株式会社 Eyewash liquid for dry eye therapy
WO2006065916A1 (en) * 2004-12-14 2006-06-22 Alcon, Inc. Method of treating dry eye disorders using 13(s)-hode and its analogs
US9161905B2 (en) * 2005-01-12 2015-10-20 Ocular Research Of Boston, Inc. Dry eye treatment
AU2012201476B2 (en) * 2005-01-12 2014-07-17 Ocular Research Of Boston, Inc Dry eye treatment
TWI393567B (en) * 2005-03-31 2013-04-21 Bausch & Lomb Composition for treating dry eye and related methods of manufacture and methods of use
TW200722109A (en) * 2005-03-31 2007-06-16 Bausch & Lomb Polysaccharide and polyol composition for treating dry eye and related methods of manufacture and methods of use
ES2532912T3 (en) 2005-06-01 2015-04-01 Edison Pharmaceuticals, Inc. Active redox therapeutic compounds for the treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers
WO2007005421A2 (en) * 2005-07-01 2007-01-11 Bausch & Lomb Incorporated Long lasting alginate dry eye, related methods of manufacture and methods of use
WO2007058935A2 (en) * 2005-11-14 2007-05-24 Bausch & Lomb Incorporated Ophthalmic composition for dry eye therapy
JP5748385B2 (en) * 2006-01-13 2015-07-15 大正製薬株式会社 O / W emulsion aqueous eye drops
JP6033177B2 (en) * 2006-01-13 2016-11-30 大正製薬株式会社 O / W emulsion aqueous eye drops
WO2007100652A2 (en) 2006-02-22 2007-09-07 Edison Pharmaceuticals, Inc. Side chain variants of redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers
US7745461B1 (en) 2006-02-27 2010-06-29 Alcon Research, Ltd. Method of treating dry eye disorders
ES2284398B2 (en) 2006-04-27 2008-12-16 Universidad Complutense De Madrid FORMULATION OF LIPOSOMAL VESICLES IN WATER SOLUTIONS WITH CHARACTERISTICS OF LAGRIMAL FILM.
US7691811B2 (en) * 2006-05-25 2010-04-06 Bodor Nicholas S Transporter-enhanced corticosteroid activity and methods and compositions for treating dry eye
CA2650478C (en) * 2006-07-07 2013-08-13 Bausch & Lomb Incorporated Compositions comprising a dissociated glucocorticoid receptor agonist and an immunosuppressive agent for treating dry eye
US20080057022A1 (en) * 2006-08-30 2008-03-06 Erning Xia Ophthalmic Pharmaceutical Compositions and Uses Thereof
US20080095754A1 (en) * 2006-10-18 2008-04-24 Burke Susan E Ophthalmic compositions comprising diglycine
US8138156B2 (en) * 2006-10-18 2012-03-20 Bausch & Lomb Incorporated Ophthalmic compositions containing diglycine
US20080093247A1 (en) * 2006-10-24 2008-04-24 Alcon Manufacturing Ltd. Packaging materials for formulations containing 2-pyrrolidone derivatives
US20080095863A1 (en) * 2006-10-24 2008-04-24 Alcon Manufacturing Ltd. 2-pyrrolidone derivatives for preservation of ophthalmic, otic and nasal compositions
US20080188573A1 (en) * 2007-02-02 2008-08-07 Alcon Research, Ltd. Use of thy1-fp transgenic mouse for the identification of ophthalmic agents
WO2008120249A1 (en) * 2007-03-30 2008-10-09 Sifi S.P.A. Pharmaceutical formulations based on apolar and polar lipids for ophthalmic use
CN101674807B (en) 2007-05-04 2013-03-20 博士伦公司 Compositions for reducing, ameliorating, treating, or preventing condition of dry eye and methods of making and using same
KR20100016285A (en) * 2007-05-07 2010-02-12 보오슈 앤드 롬 인코포레이팃드 Compositions for reducing, ameliorating, treating, or preventing condition of dry eye and methods of making and using same
WO2008154129A1 (en) * 2007-06-08 2008-12-18 Bausch & Lomb Incorporated Pharmaceutical compositions and method for treating, reducing, ameliorating, alleviating, or preventing dry eye
US20090142292A1 (en) * 2007-12-03 2009-06-04 Blackwell Richard I Method For The Mitigation of Symptoms of Dry Eye
US8629099B2 (en) * 2008-03-25 2014-01-14 Bausch & Lomb Incorporated Ophthalmic compositions comprising a dipeptide
MX2011002318A (en) 2008-09-10 2011-05-10 Edison Pharmaceuticals Inc Treatment of pervasive developmental disorders with redox-active therapeutics.
WO2010030725A1 (en) * 2008-09-15 2010-03-18 Bausch & Lomb Incorporated Compositions comprising polymers having amino sugar units and methods of making and using same
US8539938B2 (en) * 2009-03-12 2013-09-24 Ford Global Technologies, Llc Fuel systems and methods for controlling fuel systems in a vehicle with multiple fuel tanks
JP2012525399A (en) 2009-04-28 2012-10-22 エジソン ファーマシューティカルズ， インコーポレイテッド Treatment of Leber hereditary optic neuropathy and dominant hereditary optic atrophy using tocotrienol quinone
TWI478730B (en) 2009-12-03 2015-04-01 Alcon Res Ltd Ophthalmic emulsion
US8658614B2 (en) 2010-08-13 2014-02-25 The University of Texas Health Science Center Aptamer-containing compositions and methods for targeting E-selectin
US9161531B2 (en) 2011-02-23 2015-10-20 Donald R. Korb High alcohol content sanitizer
US8859525B2 (en) 2011-07-19 2014-10-14 Bausch & Lomb Incorporated Pharmaceutical compositions comprising mushroom-based polysaccharides and uses thereof
EP2758031A1 (en) 2011-09-22 2014-07-30 Bausch & Lomb Incorporated Ophthalmic gel compositions
US8664180B2 (en) 2012-02-06 2014-03-04 Bausch & Lomb Incorporated Ophthalmic compositions containing diglycine
US8324171B1 (en) 2012-02-06 2012-12-04 Bausch & Lomb Incorporated Ophthalmic compositions containing diglycine
US9278132B2 (en) 2012-02-13 2016-03-08 Bausch & Lomb Incorporated Ophthalmic pharmaceutical compositions and methods of making and using same
EP2816996B1 (en) 2012-02-24 2016-10-05 Bausch & Lomb Incorporated Ophthalmic compositions with alkoxylated natural waxes
JP6016465B2 (en) * 2012-06-12 2016-10-26 ロート製薬株式会社 Aqueous composition containing vitamins A
SG11201500994SA (en) 2012-08-10 2015-03-30 Osio Corp D B A Yolia Health Contact lens use in the treatment of an ophthalmologic condition
US9279095B2 (en) 2013-01-24 2016-03-08 Bausch & Lomb Incorporated Poly(nitrogen/amine) derivatives of a natural wax and ophthalmic compositions
AU2015229452B2 (en) 2014-03-12 2021-07-15 University Of Virginia Patent Foundation Compositions and methods for treating eye infections and disease
US9505709B2 (en) 2014-05-05 2016-11-29 Thetis Pharmaceuticals Llc Compositions and methods relating to ionic salts of peptides
KR20170023061A (en) 2014-06-18 2017-03-02 테티스 파마수티컬스 엘엘씨 Mineral amino-acid complexes of active agents
US20200383953A1 (en) 2015-11-05 2020-12-10 University Of Louisville Research Foundation, Inc. Local and regional anesthesia and analgesia
CN113024369A (en) 2015-12-17 2021-06-25 Ptc医疗公司 Compounds for the treatment of oxidative stress disorders
KR102437682B1 (en) 2016-06-03 2022-08-29 테티스 파마수티컬스 엘엘씨 Compositions and methods for salts of specialized pre-resolving mediators
US9981041B2 (en) 2016-08-23 2018-05-29 Ira Jason Salzman Ophthalmic lubricating spray
US20180296390A1 (en) * 2017-04-18 2018-10-18 David Hoare Apparatus and method for treating a number of eye conditions of a user including dry eye syndrome and/or burns to the eyes
TW201938141A (en) 2018-02-21 2019-10-01 瑞士商諾華公司 Lipid- based ophthalmic emulsion
US11141348B2 (en) 2018-02-26 2021-10-12 Olympic Ophthalmics, Inc. Treatment methods using handheld devices for disorders
EP3893842A1 (en) 2018-12-10 2021-10-20 Eternatear, Inc. Ophthalmic formulations providing durable ocular lubrication
US11471475B1 (en) 2022-03-08 2022-10-18 Ralph P. Stone Ophthalmic suspension vehicles and related methods for pharmaceutical ingredient delivery
US11679078B1 (en) 2022-03-08 2023-06-20 EternaTear, Inc. Ophthalmic formulations and related methods

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4677099A (en) * 1981-09-04 1987-06-30 Yeda Research And Development Co., Ltd. Medical processes employing a novel lipid fraction
US4421748A (en) * 1982-07-13 1983-12-20 Trager Seymour F Artificial tear aid
WO1988000824A1 (en) * 1986-07-28 1988-02-11 Liposome Technology, Inc. Liposomes with enhanced retention on mucosal tissue
US4839175A (en) * 1986-07-28 1989-06-13 Liposome Technology, Inc. Liposomes with enhanced retention on mucosal tissue
US4804539A (en) * 1986-07-28 1989-02-14 Liposome Technology, Inc. Ophthalmic liposomes
US4818537A (en) * 1986-10-21 1989-04-04 Liposome Technology, Inc. Liposome composition for treating dry eye
US4914088A (en) * 1987-04-02 1990-04-03 Thomas Glonek Dry eye treatment solution and method
US4866049A (en) * 1987-08-10 1989-09-12 Spectra Pharmaceutical Services, Inc. Ophthalmic compositionn and method of using same
CA2013755C (en) * 1989-04-05 1993-11-30 Simon Benita Medicinal emulsions

Also Published As

Publication number Publication date
GR3019478T3 (en) 1996-07-31
US5294607A (en) 1994-03-15
RU2092138C1 (en) 1997-10-10
EP0459148B1 (en) 1996-01-03
IL98237A (en) 1996-08-04
TW200396B (en) 1993-02-21
DE69115990D1 (en) 1996-02-15
JPH04279525A (en) 1992-10-05
EP0459148A2 (en) 1991-12-04
IL98237A0 (en) 1992-06-21
ES2084722T3 (en) 1996-05-16
ATE132366T1 (en) 1996-01-15
CA2043366C (en) 1999-01-05
DE69115990T2 (en) 1996-05-30
EP0459148A3 (en) 1992-10-14
AU648304B2 (en) 1994-04-21
JP3281392B2 (en) 2002-05-13
AU7619191A (en) 1992-08-06

Similar Documents

Publication Publication Date Title
CA2043366A1 (en) Dry eye treatment process and solution
CA2159606A1 (en) Skin care composition containing emulsified petroleum jelly
CA2230243A1 (en) Methods and agents for improving paper printability and strength
DE2963119D1 (en) Process for the preparation of aqueous dispersions or solutions of polyurethane-polyurea and their use
FR2720644B1 (en) Water-in-oil emulsion without surfactant.
UA42690C2 (en) THE MODIFIED MATERIAL, MODIFIED THE ANTIMIKROBNNYY MATERIAL, THE METHOD OF OBTAINING THE MODIFIED MATERIAL, THE METHOD OF THE FORMATION OF ANTIMICROBIC COATING ON THE INSTRUMENT And THE MEDICAL INSTRUMENT, INTENDED FOR THE USE In THE CONTACT With THE ELECTROLYTE ON THE BASIS OF ALCOHOL OR WATER, I has ON BY SOYA OF SURFACE THE ANTIMICROBIC COATING
AU581937B2 (en) Surface coating agent and method for using the same
CA2019410A1 (en) Liquid polymer composition, and method of use
DE3874479T2 (en) SOLUTION FOR TREATING DRY-EYE DISEASES.
CA2110455A1 (en) Quaternized polyvinylamine water clarification agents
CA2049594A1 (en) Environmentally safe cleaning process and cleaning composition useful therin
AU9020591A (en) Method of treatment of waste paper or the like
CA2191825A1 (en) Process for Dye Removal
AU4028395A (en) Cosmetic or dermatological composition in the form of a water-in-oil emulsion with a high content of hydroxy acids
AU557929B2 (en) Synthetic polymer coat for differential release of active substance
CA2077254A1 (en) Parasiticidal composition and methods for its making and use
AU2628192A (en) Polish composition forming hydrophilic layer and spray-away polishing process
CA2039773A1 (en) Cosmetic composition or aqueous dermo-pharmaceutical containing a suspension of hydrophile lipidic substance hydrated
HU204868B (en) Process for producing priming or body color having active surface cleaning and corrosion preventive effect
EP0354889A3 (en) A method of controlling microbiological deposits on paper making equipment and paper obtained thereby
EP0413260A3 (en) Surface treatment chemicals for forming hydrophilic coatings, treatment bath containing them, and treatment method
NO158984C (en) APPLICATION OF (S) -BETA-FARNESEN IN LIQUID FORM OR OF A (E) -BETA-FARNESEN-CONTAINING LIQUID AS A CONTACT INSECTICIDE AGAINST ALEPHUS.
BR9917129A (en) Method and apparatus for forming a decorative pattern in a liquid coating applicator
AU567753B2 (en) Method of deodorising
JPS56133214A (en) Novel method of coating at least one kind of medicinally active component, novel drug obtained thereby and composition containing same

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry